Denver Investment Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q1 | – | Sell |
-5,490
| Closed | -$517K | – | 466 |
|
|
2015
Q4 | $517K | Buy |
5,490
+310
| +6% | +$29.2K | 0.02% | 346 |
|
|
2015
Q3 | $416K | Buy |
5,180
+321
| +7% | +$25.8K | 0.02% | 364 |
|
|
2015
Q2 | $582K | Sell |
4,859
-14,929
| -75% | -$1.79M | 0.02% | 351 |
|
|
2015
Q1 | $2.07M | Sell |
19,788
-17,688
| -47% | -$1.85M | 0.07% | 271 |
|
|
2014
Q4 | $3.64M | Buy |
37,476
+313
| +0.8% | +$30.4K | 0.12% | 193 |
|
|
2014
Q3 | $2.9M | Sell |
37,163
-554
| -1% | -$43.3K | 0.1% | 225 |
|
|
2014
Q2 | $2.38M | Sell |
37,717
-35,876
| -49% | -$2.27M | 0.07% | 268 |
|
|
2014
Q1 | $4.94M | Buy |
73,593
+19,484
| +36% | +$1.31M | 0.15% | 185 |
|
|
2013
Q4 | $3.48K | Sell |
54,109
-56,284
| -51% | -$3.62K | 0.1% | 236 |
|
|
2013
Q3 | $7.07M | Buy |
110,393
+40,900
| +59% | +$2.62M | 0.15% | 190 |
|
|
2013
Q2 | $2.15M | Buy |
+69,493
| New | +$2.15M | 0.05% | 315 |
|